| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HSP90 Heat-Shock Proteins | 45 | 2022 | 61 | 7.580 |
Why?
|
| Molecular Chaperones | 16 | 2015 | 50 | 2.930 |
Why?
|
| Reticulocytes | 33 | 2013 | 41 | 2.070 |
Why?
|
| Cell Cycle Proteins | 13 | 2012 | 187 | 1.820 |
Why?
|
| eIF-2 Kinase | 21 | 2005 | 29 | 1.680 |
Why?
|
| Heme | 21 | 2005 | 91 | 1.550 |
Why?
|
| Drosophila Proteins | 9 | 2006 | 44 | 1.410 |
Why?
|
| Rabbits | 39 | 2013 | 277 | 1.120 |
Why?
|
| Proteome | 4 | 2018 | 79 | 0.990 |
Why?
|
| High-Throughput Screening Assays | 4 | 2018 | 39 | 0.920 |
Why?
|
| Protein Binding | 19 | 2022 | 667 | 0.840 |
Why?
|
| Protein Folding | 15 | 2013 | 47 | 0.830 |
Why?
|
| Luciferases | 9 | 2018 | 54 | 0.810 |
Why?
|
| Protein Biosynthesis | 12 | 2006 | 111 | 0.780 |
Why?
|
| Proteomics | 4 | 2018 | 197 | 0.780 |
Why?
|
| Animals | 58 | 2018 | 10684 | 0.680 |
Why?
|
| Novobiocin | 8 | 2013 | 16 | 0.650 |
Why?
|
| Benzoquinones | 15 | 2013 | 26 | 0.650 |
Why?
|
| Lactams, Macrocyclic | 15 | 2013 | 26 | 0.650 |
Why?
|
| Heat-Shock Proteins | 7 | 1998 | 38 | 0.640 |
Why?
|
| HSP70 Heat-Shock Proteins | 6 | 2011 | 45 | 0.640 |
Why?
|
| Antineoplastic Agents | 8 | 2022 | 686 | 0.630 |
Why?
|
| Protein Kinases | 7 | 2005 | 155 | 0.620 |
Why?
|
| Proteins | 12 | 1996 | 254 | 0.590 |
Why?
|
| Quinones | 11 | 2005 | 23 | 0.550 |
Why?
|
| Enzyme Inhibitors | 12 | 2013 | 251 | 0.500 |
Why?
|
| Myoblasts | 2 | 2005 | 9 | 0.470 |
Why?
|
| Protein Interaction Maps | 1 | 2015 | 11 | 0.450 |
Why?
|
| Peptide Initiation Factors | 10 | 1998 | 11 | 0.450 |
Why?
|
| Phosphorylation | 19 | 2012 | 585 | 0.440 |
Why?
|
| Protein Conformation | 13 | 2011 | 258 | 0.420 |
Why?
|
| Nitric Oxide | 3 | 2005 | 153 | 0.420 |
Why?
|
| Cullin Proteins | 1 | 2014 | 12 | 0.420 |
Why?
|
| GTP-Binding Proteins | 1 | 2014 | 46 | 0.420 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2014 | 51 | 0.410 |
Why?
|
| Carbon Monoxide | 3 | 2005 | 47 | 0.410 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 72 | 0.410 |
Why?
|
| Small Molecule Libraries | 3 | 2013 | 19 | 0.390 |
Why?
|
| Chaperonins | 6 | 2012 | 6 | 0.380 |
Why?
|
| Enzyme Activation | 13 | 2006 | 267 | 0.380 |
Why?
|
| Protein-Tyrosine Kinases | 5 | 2001 | 97 | 0.380 |
Why?
|
| Protein Structure, Tertiary | 9 | 2011 | 284 | 0.370 |
Why?
|
| Humans | 35 | 2022 | 28851 | 0.360 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2005 | 140 | 0.350 |
Why?
|
| Amino Acid Sequence | 13 | 2011 | 697 | 0.350 |
Why?
|
| Multiprotein Complexes | 1 | 2012 | 54 | 0.350 |
Why?
|
| Xanthones | 1 | 2011 | 6 | 0.350 |
Why?
|
| Hemin | 7 | 1998 | 14 | 0.340 |
Why?
|
| Tandem Mass Spectrometry | 4 | 2018 | 117 | 0.340 |
Why?
|
| Luciferases, Firefly | 2 | 2007 | 4 | 0.330 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2018 | 58 | 0.330 |
Why?
|
| Biological Products | 1 | 2011 | 67 | 0.320 |
Why?
|
| Molybdenum | 4 | 2004 | 8 | 0.310 |
Why?
|
| Eukaryotic Initiation Factor-2 | 12 | 2000 | 20 | 0.290 |
Why?
|
| Antimicrobial Cationic Peptides | 2 | 2018 | 34 | 0.290 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2005 | 157 | 0.270 |
Why?
|
| Cell Line | 6 | 2018 | 700 | 0.270 |
Why?
|
| Chromatography, Liquid | 3 | 2018 | 79 | 0.270 |
Why?
|
| Adenosine Triphosphate | 6 | 2022 | 121 | 0.270 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 5 | 2004 | 18 | 0.270 |
Why?
|
| Cell Differentiation | 4 | 2005 | 427 | 0.270 |
Why?
|
| Serine | 2 | 2005 | 51 | 0.260 |
Why?
|
| Carrier Proteins | 2 | 1999 | 255 | 0.260 |
Why?
|
| Protein Denaturation | 6 | 2013 | 28 | 0.260 |
Why?
|
| Molecular Sequence Data | 10 | 2011 | 1056 | 0.260 |
Why?
|
| src-Family Kinases | 5 | 2005 | 71 | 0.250 |
Why?
|
| Phosphoprotein Phosphatases | 2 | 2005 | 39 | 0.240 |
Why?
|
| Amino Acids | 3 | 2003 | 85 | 0.240 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2005 | 7 | 0.240 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2005 | 12 | 0.240 |
Why?
|
| Models, Molecular | 5 | 2011 | 452 | 0.230 |
Why?
|
| Structure-Activity Relationship | 6 | 2018 | 209 | 0.230 |
Why?
|
| Cell Line, Tumor | 8 | 2018 | 1350 | 0.220 |
Why?
|
| Drug Design | 2 | 2018 | 63 | 0.220 |
Why?
|
| Binding Sites | 5 | 2022 | 355 | 0.210 |
Why?
|
| Kinetics | 11 | 1998 | 553 | 0.210 |
Why?
|
| Mutagenesis, Site-Directed | 5 | 2005 | 132 | 0.210 |
Why?
|
| Recombinant Proteins | 6 | 2005 | 416 | 0.210 |
Why?
|
| HeLa Cells | 3 | 2015 | 212 | 0.210 |
Why?
|
| Signal Transduction | 3 | 2005 | 1469 | 0.210 |
Why?
|
| Oncogene Protein pp60(v-src) | 2 | 2012 | 6 | 0.200 |
Why?
|
| Cell-Free System | 8 | 1997 | 21 | 0.200 |
Why?
|
| Protein Synthesis Inhibitors | 3 | 1998 | 13 | 0.190 |
Why?
|
| Immunoprecipitation | 2 | 2014 | 68 | 0.190 |
Why?
|
| beta-Defensins | 2 | 2018 | 2 | 0.180 |
Why?
|
| HSC70 Heat-Shock Proteins | 4 | 2004 | 7 | 0.180 |
Why?
|
| Neoplasms | 3 | 2021 | 874 | 0.170 |
Why?
|
| Pentacyclic Triterpenes | 2 | 2011 | 3 | 0.170 |
Why?
|
| Triterpenes | 2 | 2011 | 9 | 0.170 |
Why?
|
| Hot Temperature | 2 | 1999 | 87 | 0.160 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 249 | 0.160 |
Why?
|
| Cell Proliferation | 5 | 2011 | 824 | 0.160 |
Why?
|
| Peptides | 1 | 2002 | 296 | 0.150 |
Why?
|
| Metals | 2 | 1991 | 41 | 0.150 |
Why?
|
| Swine Diseases | 1 | 2018 | 13 | 0.150 |
Why?
|
| Enterocytes | 1 | 2018 | 15 | 0.150 |
Why?
|
| Hydrolysis | 3 | 2010 | 60 | 0.150 |
Why?
|
| Heat-Shock Response | 1 | 2018 | 13 | 0.140 |
Why?
|
| Guanosine Diphosphate | 6 | 2000 | 18 | 0.140 |
Why?
|
| Mutation | 6 | 2005 | 867 | 0.140 |
Why?
|
| Swine | 1 | 2018 | 238 | 0.140 |
Why?
|
| Peptide Chain Elongation, Translational | 1 | 1997 | 4 | 0.140 |
Why?
|
| Anemia | 1 | 1998 | 43 | 0.140 |
Why?
|
| RNA, Double-Stranded | 5 | 1996 | 15 | 0.130 |
Why?
|
| In Vitro Techniques | 4 | 1999 | 242 | 0.130 |
Why?
|
| Prostatic Neoplasms | 2 | 2011 | 302 | 0.130 |
Why?
|
| Blotting, Western | 7 | 2013 | 515 | 0.130 |
Why?
|
| Chromatography, Affinity | 3 | 2010 | 32 | 0.130 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1997 | 94 | 0.130 |
Why?
|
| K562 Cells | 3 | 2005 | 20 | 0.130 |
Why?
|
| Stress, Physiological | 1 | 1997 | 96 | 0.130 |
Why?
|
| Cisplatin | 1 | 1997 | 186 | 0.120 |
Why?
|
| Macromolecular Substances | 5 | 2002 | 53 | 0.120 |
Why?
|
| Lymphocytes | 1 | 1996 | 90 | 0.120 |
Why?
|
| Interferon-beta | 1 | 1996 | 40 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2013 | 612 | 0.120 |
Why?
|
| Cells, Cultured | 6 | 2018 | 1022 | 0.120 |
Why?
|
| Mice | 7 | 2012 | 4802 | 0.120 |
Why?
|
| Leupeptins | 1 | 2015 | 7 | 0.110 |
Why?
|
| Okadaic Acid | 2 | 2005 | 5 | 0.110 |
Why?
|
| RNA, Messenger | 5 | 2006 | 668 | 0.110 |
Why?
|
| Protein Refolding | 1 | 2013 | 1 | 0.100 |
Why?
|
| Cell Survival | 3 | 2018 | 419 | 0.100 |
Why?
|
| DNA, Complementary | 3 | 2000 | 78 | 0.100 |
Why?
|
| Tyrosine | 2 | 2012 | 92 | 0.100 |
Why?
|
| Growth Inhibitors | 2 | 2011 | 11 | 0.100 |
Why?
|
| Resorcinols | 1 | 2013 | 3 | 0.100 |
Why?
|
| Isoxazoles | 1 | 2013 | 8 | 0.100 |
Why?
|
| Mass Spectrometry | 1 | 2014 | 196 | 0.100 |
Why?
|
| Leucine | 1 | 1992 | 20 | 0.100 |
Why?
|
| Ribosomes | 4 | 2006 | 32 | 0.100 |
Why?
|
| Guanosine Triphosphate | 3 | 1996 | 29 | 0.090 |
Why?
|
| Protein Renaturation | 1 | 2012 | 4 | 0.090 |
Why?
|
| Catalysis | 2 | 2004 | 133 | 0.090 |
Why?
|
| Cell Extracts | 1 | 2012 | 14 | 0.090 |
Why?
|
| Receptors, Progesterone | 1 | 2012 | 17 | 0.090 |
Why?
|
| Cell Division | 2 | 2007 | 154 | 0.090 |
Why?
|
| Coleoptera | 3 | 1998 | 15 | 0.090 |
Why?
|
| Apoptosis | 3 | 2009 | 780 | 0.090 |
Why?
|
| Disulfides | 1 | 1991 | 34 | 0.090 |
Why?
|
| Peptide Hydrolases | 1 | 2011 | 22 | 0.090 |
Why?
|
| Drug Discovery | 1 | 2011 | 37 | 0.090 |
Why?
|
| Stereoisomerism | 1 | 2011 | 45 | 0.090 |
Why?
|
| Silymarin | 1 | 2010 | 6 | 0.090 |
Why?
|
| Guanine Nucleotide Exchange Factors | 7 | 1996 | 30 | 0.090 |
Why?
|
| Peptide Chain Initiation, Translational | 3 | 1989 | 6 | 0.080 |
Why?
|
| Neoplasm Proteins | 1 | 2011 | 123 | 0.080 |
Why?
|
| Crystallography, X-Ray | 1 | 2011 | 222 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2001 | 109 | 0.080 |
Why?
|
| Protein Isoforms | 2 | 2021 | 119 | 0.080 |
Why?
|
| Cell Line, Transformed | 2 | 2000 | 42 | 0.070 |
Why?
|
| Naphthoquinones | 1 | 2008 | 11 | 0.070 |
Why?
|
| Histidine | 3 | 2003 | 53 | 0.070 |
Why?
|
| Adenosine Triphosphatases | 1 | 2009 | 50 | 0.070 |
Why?
|
| Isoflavones | 1 | 2007 | 8 | 0.070 |
Why?
|
| Guanine Nucleotides | 1 | 1987 | 4 | 0.070 |
Why?
|
| Enzyme Stability | 2 | 1998 | 31 | 0.070 |
Why?
|
| Gene Expression Regulation | 3 | 2018 | 634 | 0.070 |
Why?
|
| Ethylmaleimide | 2 | 1997 | 6 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2018 | 202 | 0.070 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 236 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 536 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2006 | 233 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 257 | 0.060 |
Why?
|
| Cyclin A | 1 | 2005 | 2 | 0.060 |
Why?
|
| Protein Phosphatase 2 | 1 | 2005 | 11 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2006 | 55 | 0.060 |
Why?
|
| Models, Biological | 2 | 1999 | 469 | 0.060 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 66 | 0.060 |
Why?
|
| Drosophila melanogaster | 1 | 2006 | 62 | 0.060 |
Why?
|
| Amino Acid Substitution | 1 | 2005 | 104 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2005 | 7 | 0.060 |
Why?
|
| Gene Deletion | 1 | 2005 | 120 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2018 | 169 | 0.060 |
Why?
|
| Dithiothreitol | 2 | 1997 | 5 | 0.060 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2005 | 32 | 0.060 |
Why?
|
| Rats | 4 | 2011 | 1588 | 0.060 |
Why?
|
| Centrifugation, Density Gradient | 3 | 1997 | 26 | 0.060 |
Why?
|
| Jurkat Cells | 3 | 2013 | 30 | 0.060 |
Why?
|
| Crystallography | 1 | 2004 | 6 | 0.060 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2004 | 7 | 0.050 |
Why?
|
| Autoradiography | 1 | 2004 | 29 | 0.050 |
Why?
|
| Peptide Mapping | 1 | 2004 | 22 | 0.050 |
Why?
|
| Protein Structure, Secondary | 1 | 2004 | 130 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-hck | 2 | 2001 | 4 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 787 | 0.050 |
Why?
|
| Phosphotransferases | 1 | 2003 | 16 | 0.050 |
Why?
|
| Alkaline Phosphatase | 1 | 2003 | 31 | 0.050 |
Why?
|
| Glutamic Acid | 1 | 2003 | 50 | 0.050 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2003 | 55 | 0.050 |
Why?
|
| Point Mutation | 1 | 2003 | 61 | 0.050 |
Why?
|
| Glutathione Disulfide | 2 | 1998 | 14 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 2001 | 314 | 0.050 |
Why?
|
| Cloning, Molecular | 3 | 2000 | 208 | 0.050 |
Why?
|
| Arachidonic Acid | 1 | 2002 | 19 | 0.050 |
Why?
|
| Coumarins | 1 | 2022 | 5 | 0.050 |
Why?
|
| Allosteric Site | 1 | 2022 | 11 | 0.050 |
Why?
|
| Peptides, Cyclic | 1 | 2002 | 30 | 0.050 |
Why?
|
| Cyclic AMP | 2 | 1993 | 96 | 0.050 |
Why?
|
| Glutathione | 2 | 1997 | 76 | 0.050 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2002 | 68 | 0.050 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2001 | 14 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2001 | 32 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2001 | 139 | 0.040 |
Why?
|
| Isoleucine | 1 | 2000 | 3 | 0.040 |
Why?
|
| Proline | 1 | 2000 | 11 | 0.040 |
Why?
|
| Polyribosomes | 3 | 1997 | 6 | 0.040 |
Why?
|
| Base Sequence | 3 | 1996 | 588 | 0.040 |
Why?
|
| Caspases | 1 | 2000 | 43 | 0.040 |
Why?
|
| Deoxyribonucleases | 1 | 1979 | 6 | 0.040 |
Why?
|
| Lead | 2 | 1991 | 9 | 0.040 |
Why?
|
| Endonucleases | 1 | 1979 | 17 | 0.040 |
Why?
|
| Mercury | 2 | 1991 | 12 | 0.040 |
Why?
|
| Cadmium | 2 | 1991 | 16 | 0.040 |
Why?
|
| Clofibric Acid | 1 | 1999 | 1 | 0.040 |
Why?
|
| Corticosterone | 1 | 1979 | 35 | 0.040 |
Why?
|
| Temperature | 1 | 2000 | 213 | 0.040 |
Why?
|
| Somites | 1 | 1999 | 2 | 0.040 |
Why?
|
| Macrophages | 2 | 2018 | 305 | 0.040 |
Why?
|
| Endopeptidases | 1 | 1999 | 20 | 0.040 |
Why?
|
| Phosphates | 1 | 1999 | 33 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 1979 | 138 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 1992 | 336 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 1999 | 151 | 0.040 |
Why?
|
| Gene Expression | 1 | 2000 | 417 | 0.040 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 1998 | 2 | 0.040 |
Why?
|
| Histone Deacetylases | 1 | 2018 | 26 | 0.040 |
Why?
|
| Molecular Structure | 2 | 2010 | 245 | 0.040 |
Why?
|
| Avian Proteins | 1 | 2018 | 5 | 0.040 |
Why?
|
| Jejunum | 1 | 2018 | 9 | 0.040 |
Why?
|
| Tissue Culture Techniques | 1 | 2018 | 31 | 0.040 |
Why?
|
| Chickens | 1 | 2018 | 62 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2000 | 285 | 0.040 |
Why?
|
| Zebrafish | 1 | 1999 | 96 | 0.040 |
Why?
|
| src Homology Domains | 1 | 1998 | 31 | 0.040 |
Why?
|
| Erythrocyte Aging | 1 | 1998 | 6 | 0.030 |
Why?
|
| Hydrogen Bonding | 1 | 2018 | 39 | 0.030 |
Why?
|
| Solutions | 1 | 1998 | 31 | 0.030 |
Why?
|
| Buffers | 1 | 1998 | 25 | 0.030 |
Why?
|
| Luminescent Measurements | 1 | 1998 | 31 | 0.030 |
Why?
|
| Ditiocarb | 1 | 1997 | 6 | 0.030 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1997 | 12 | 0.030 |
Why?
|
| Cross-Linking Reagents | 1 | 1997 | 43 | 0.030 |
Why?
|
| Time Factors | 2 | 2000 | 1613 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 148 | 0.030 |
Why?
|
| Oligopeptides | 1 | 1998 | 97 | 0.030 |
Why?
|
| Rifabutin | 1 | 1996 | 4 | 0.030 |
Why?
|
| Poliovirus | 1 | 1996 | 1 | 0.030 |
Why?
|
| Male | 5 | 2018 | 13921 | 0.030 |
Why?
|
| Poliomyelitis | 1 | 1996 | 6 | 0.030 |
Why?
|
| RNA | 1 | 1997 | 111 | 0.030 |
Why?
|
| Liver | 1 | 1979 | 471 | 0.030 |
Why?
|
| 3T3 Cells | 1 | 1996 | 46 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 1998 | 404 | 0.030 |
Why?
|
| Viral Proteins | 1 | 1996 | 63 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 1997 | 165 | 0.030 |
Why?
|
| Edetic Acid | 2 | 1991 | 5 | 0.030 |
Why?
|
| Rhodamines | 1 | 2013 | 10 | 0.030 |
Why?
|
| Lactalbumin | 1 | 1993 | 1 | 0.030 |
Why?
|
| Biological Assay | 1 | 2013 | 34 | 0.030 |
Why?
|
| Lactoglobulins | 1 | 1993 | 2 | 0.030 |
Why?
|
| Immunosorbent Techniques | 1 | 1993 | 12 | 0.030 |
Why?
|
| Coloring Agents | 1 | 2013 | 37 | 0.030 |
Why?
|
| Serum Albumin, Bovine | 1 | 1993 | 22 | 0.030 |
Why?
|
| Electron Spin Resonance Spectroscopy | 2 | 2003 | 35 | 0.030 |
Why?
|
| Spectrum Analysis, Raman | 2 | 2003 | 32 | 0.030 |
Why?
|
| Macrolides | 1 | 2013 | 19 | 0.030 |
Why?
|
| Eukaryotic Initiation Factor-2B | 1 | 1993 | 1 | 0.030 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1992 | 6 | 0.020 |
Why?
|
| Carbon Radioisotopes | 1 | 1992 | 20 | 0.020 |
Why?
|
| Catalytic Domain | 2 | 2003 | 79 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2012 | 44 | 0.020 |
Why?
|
| COS Cells | 1 | 2012 | 49 | 0.020 |
Why?
|
| Fungal Proteins | 1 | 1993 | 83 | 0.020 |
Why?
|
| Circular Dichroism | 2 | 2003 | 43 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 1993 | 119 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1993 | 115 | 0.020 |
Why?
|
| Cations, Divalent | 1 | 1991 | 14 | 0.020 |
Why?
|
| NADP | 1 | 1991 | 39 | 0.020 |
Why?
|
| Hemolysis | 1 | 1991 | 51 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1993 | 178 | 0.020 |
Why?
|
| Cattle | 2 | 2006 | 389 | 0.020 |
Why?
|
| Spodoptera | 1 | 2010 | 4 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 1991 | 380 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2009 | 30 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2009 | 37 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1989 | 122 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 1993 | 490 | 0.020 |
Why?
|
| Cell Death | 1 | 2009 | 119 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2008 | 34 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2009 | 163 | 0.020 |
Why?
|
| Receptor, ErbB-2 | 1 | 2008 | 33 | 0.020 |
Why?
|
| Immunoassay | 1 | 1988 | 36 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2009 | 292 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2000 | 133 | 0.020 |
Why?
|
| Globins | 1 | 1986 | 3 | 0.020 |
Why?
|
| Codon, Initiator | 1 | 2006 | 6 | 0.020 |
Why?
|
| Biological Transport | 1 | 2006 | 128 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 1986 | 120 | 0.010 |
Why?
|
| DNA Repair | 1 | 2006 | 82 | 0.010 |
Why?
|
| Aorta | 1 | 2006 | 124 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2006 | 179 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 2003 | 34 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2003 | 40 | 0.010 |
Why?
|
| Ligands | 1 | 2003 | 178 | 0.010 |
Why?
|
| Magnesium | 1 | 1983 | 42 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2006 | 334 | 0.010 |
Why?
|
| Models, Chemical | 1 | 1983 | 90 | 0.010 |
Why?
|
| Oncogene Protein v-cbl | 1 | 2001 | 1 | 0.010 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2001 | 1 | 0.010 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 2001 | 9 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2003 | 338 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2001 | 157 | 0.010 |
Why?
|
| Mitogens | 1 | 2000 | 3 | 0.010 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2000 | 13 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2000 | 30 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2000 | 17 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 2000 | 29 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2000 | 58 | 0.010 |
Why?
|
| Polynucleotide Adenylyltransferase | 1 | 1979 | 1 | 0.010 |
Why?
|
| Hypophysectomy | 1 | 1979 | 4 | 0.010 |
Why?
|
| Poly A | 1 | 1979 | 5 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2000 | 24 | 0.010 |
Why?
|
| Exonucleases | 1 | 1979 | 5 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2000 | 66 | 0.010 |
Why?
|
| Adrenalectomy | 1 | 1979 | 13 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2000 | 80 | 0.010 |
Why?
|
| Cytosol | 1 | 1979 | 49 | 0.010 |
Why?
|
| Spleen | 1 | 2000 | 113 | 0.010 |
Why?
|
| Notochord | 1 | 1999 | 1 | 0.010 |
Why?
|
| Colforsin | 1 | 1999 | 12 | 0.010 |
Why?
|
| Zebrafish Proteins | 1 | 1999 | 20 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 1999 | 25 | 0.010 |
Why?
|
| Fasting | 1 | 1979 | 91 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2000 | 210 | 0.010 |
Why?
|
| Muscles | 1 | 1999 | 73 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2000 | 150 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 1999 | 79 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1999 | 129 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 1999 | 154 | 0.010 |
Why?
|
| Phenotype | 1 | 1999 | 685 | 0.010 |
Why?
|
| Heat Stress Disorders | 1 | 1996 | 4 | 0.010 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 1996 | 6 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 1996 | 23 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1996 | 554 | 0.010 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 1993 | 26 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 1996 | 677 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 1984 | 6 | 0.000 |
Why?
|